Clinuvel Pharmaceuticals LtdCUVL
Price (close)
$5.63
Market cap
—
P/E
—
Revenue (FY)
—
Net income
—
Dividend yield
0.64%
1-year total return
-27.0%
Net margin
—
Revenue growth
—
Debt / equity
—
What Clinuvel Pharmaceuticals Ltd does.
No business description on file yet.
More on CUVL.
- Clinuvel Pharmaceuticals Ltd summary
- Clinuvel Pharmaceuticals Ltd financial statements
- Clinuvel Pharmaceuticals Ltd key metrics
- Clinuvel Pharmaceuticals Ltd health scores and style box
- Clinuvel Pharmaceuticals Ltd earnings
- Clinuvel Pharmaceuticals Ltd dividends
- Clinuvel Pharmaceuticals Ltd valuation
- Clinuvel Pharmaceuticals Ltd ownership and insiders
- Clinuvel Pharmaceuticals Ltd peers
Figures from Clinuvel Pharmaceuticals Ltd's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.